Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer

Completed · Phase 1

Conditions studied: Prostate Cancer

In brief

RATIONALE: Calcitriol may help prostate cancer cells develop into normal cells. Zoledronate may delay or prevent the formation of bone metastases. Combining calcitriol and zoledronate may be an effective treatment for progressive prostate cancer. PURPOSE: Phase I trial to study the effectiveness of combining calcitriol with zoledronate in treating patients who have progressive prostate cancer.

Key facts

Study ID

NCT00004928

Run by

Memorial Sloan Kettering Cancer Center

Starts

1999-10-01

Expected to finish

2004-10-01

Last updated by the study team

2013-06-19

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.